Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

906.00p
   
  • Change Today:
    -46.00p
  • 52 Week High: 906.00p
  • 52 Week Low: 906.00p
  • Currency: UK Pounds
  • Shares Issued: 6.04m
  • Volume: 15,058
  • Market Cap: £54.73m
  • RiskGrade: 340

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Alexis M. Sandler 187,727 £1,700,807
Vladislav Sandler Ph.D. 103,862 £940,990
Peter Redmond 13,991 £126,758

Major Shareholders

Notifier** Holding Value*
David John Smith 468,923 £4,248,442
Alexis Sandler 187,726 £1,700,798
Dr Vladislav Sandler 103,862 £940,990
Optiva Securities Limited 70,329 £637,181
Flascherberg Capital Anstalt 69,991 £634,118
Craig Auringer 59,593 £539,913
HSBC Client Holdings Nominee (UK) Limited 45,160 £409,150
Ron Valk 42,828 £388,022
Samantha Bauer 42,706 £386,916
Plum Capital 29,232 £264,842
43 North LLC 28,429 £257,567
Abdelatif LACHAB 6,500 £58,890
Wayne Gibson 6,500 £58,890

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 906.00p
Change Today -46.00p
% Change -4.83 %
52 Week High 906.00p
52 Week Low 906.00p
Volume 15,058
Shares Issued 6.04m
Market Cap £54.73m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47% below the market average47% below the market average47% below the market average47% below the market average47% below the market average
56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average
Price Trend
91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average
90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page